Compare Gilead Sciences, Inc. (GILD) vs Waste Management, Inc. (WM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Gilead Sciences, Inc. vs Waste Management, Inc. — how do they compare? Gilead Sciences, Inc. trades at $146.25 (market cap $182.40B), while Waste Management, Inc. trades at $209.85 (market cap $83.98B). The key difference: Gilead Sciences, Inc. is far larger — about 2.2× Waste Management, Inc.'s market cap, and Gilead Sciences, Inc. pays the higher dividend (2.23%). Which is the better fit depends on your goals — on Pluang, investors hold Gilead Sciences, Inc. for 111 Days and Waste Management, Inc. for 130 Days on average.
| GILD | WM | |
|---|---|---|
Market Cap | $182.40B | $83.98B |
Volume | 4,469,821 | 2,182,180 |
Sector | Health | Industrials |
52-Week High | $155.80 | $246.51 |
52-Week Low | $116.74 | $196.77 |
Typical Hold Time | 111 Days | 130 Days |
Enterprise Value | $205.46B | $106.78B |
Dividend Yield | 2.23% | 1.8% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Gilead Sciences (GILD) trades at $146.85, up 1.82% today, with a bullish technical signal from moving averages and recent earnings beats in Q4 2025 and Q1 2026. The company reported strong 2025 revenue of $29.44B and net income of $8.51B, though 2026 projections show a net loss. Key developments include a partnership with PAHO to expand HIV prevention drug access in Latin America, supporting long-term growth prospects amid mixed profitability metrics.
The outlook for GILD is cautiously optimistic, driven by analyst consensus favoring a buy rating (65.52%) and a price target of $151.57. Opportunities lie in HIV and oncology pipeline advancements, but risks include negative 2026 profit margins and high debt levels. Investors should weigh strong cash flow from operations against execution risks in a competitive biopharma landscape.
Waste Management (WM) trades at $208.94, up 0.51% with mixed technical signals showing bearish moving averages but neutral oscillators. The company demonstrates strong fundamentals with $25.2B revenue in 2025, 11.12% net margin, and consistent earnings beats in recent quarters. Recent news highlights WM's defensive business model and dividend reliability, while analyst consensus remains strongly positive with 57% buy ratings.
WM presents a compelling long-term investment with stable cash flows and dividend growth potential, though elevated debt levels and near-term technical weakness warrant caution. The stock's premium valuation (P/E 29.55) reflects quality but limits near-term upside absent significant earnings acceleration.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Gilead Sciences, Inc.
Gilead Sciences develops and markets therapies to treat life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. The acquisitions of Corus Pharma, Myogen, CV Therapeutics, Arresto Biosciences, and Calistoga have broadened this focus to include pulmonary and cardiovascular diseases and cancer. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of combination drug Harvoni, and the Kite, Forty Seven, and Immunomedics acquisitions boost Gilead's exposure to cell therapy and noncell therapy in oncology.
Read more on GILD →About Waste Management, Inc.
Waste Management ranks as the largest integrated provider of traditional solid waste services in the United States, operating approximately 260 active landfills and about 340 transfer stations. The company serves residential, commercial, and industrial end markets and is also a leading recycler in North America.
Read more on WM →
